ASIF News No. 8 (October 2008)

Austria to welcome ASIF delegates in October 2009    

The 9ih ASIF Council meeting will take place from October 15th to October 18th, 2009 in Bad Hofgastein, a market town and the historical hub of the Gastein Valley in Austria. It is located in the sunniest and broadest point of the valley and  is an old-established spa and winter sports resort.

Efficacy of Radon thermal gallery therapy in ankylosing spondylitis    

The combination of hyperthermy and radon inhalation has an anti-inflammatory effect and enables many patients to reduce their consumption of inflammatory drugs. Since the risk connected with NSAIDs is much higher than the possible risk connected with the low-dose radon therapy, the treatment in Gastein is a risk-reducing therapy of AS.

ASIF contributes to ASASQoL questionnaire    

Members of the Steering Committee of the Assessment of Spondyloarthritis international Society (ASAS)  invited 12 patients with AS to contribute to the ASAS Quality of Life questionnaire at a workshop in Düsseldorf, Germany,.

ASIF booklet on AS assessment and criteria    

Methods usually applied in the assessment of of the course of the disease, as well as classification and diagnostic criteria of AS and the spondyloarthritides are collected in a booklet created by ASIF vice president Ernst Feldtkeller in cooperation with members of ASAS.

Evidence of therapy forms in treating ankylosing spondylitis    

Random-controlled studies are not the only way to reach evidence of the usefullness of therapy forms. The usefullness of physical therapy and of extended patient instruction is plausibility and experience without such studies.

The place of physical therapy in the treatment of ankylosing spondylitis    

Also Professor Asim Khan and his colleague Mazen Elyan in Cleveland, Ohio, summarize important recommendations for the physical therapy and extended instruction of patients with AS.

The ACE campaign to end discrimination against people with arthritis    

The Arthritis Consumer Experts (ACE) launched a successful campain and introduced a JointHealth™ Report Card on provincial formulary listings for biologic response modifiers in Canada 

Patient Advocacy is working    

In the summer of 2007 the Canadian Spondylitis Association (CSA) decided to take their meeting to Alberta to help raise the awareness of the need for patient coverage of the new biologics. 

Package inserts made readable    

In Germany, a group of patients with different diseases joined to create examples of user-friendly package information leaflets and presented the result in a successful press conference